Welcome to LookChem.com Sign In|Join Free

CAS

  • or

329794-09-4

Post Buying Request

329794-09-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

329794-09-4 Usage

General Description

4-(tert-butyl-dimethyl-silanyloxymethyl)-pyridin-2-ylamine is a chemical compound that contains a pyridine ring with an amine functional group and a silanyloxymethyl substituent. The silanyloxymethyl group consists of a silicon atom bonded to three methyl groups and an oxygen atom. 4-(TERT-BUTYL-DIMETHYL-SILANYLOXYMETHYL)-PYRIDIN-2-YLAMINE is likely to have applications in organic synthesis and chemical processes involving silicon-based reagents. It may also be used in the development of pharmaceuticals and agrochemicals, as well as in the production of advanced materials and specialty chemicals. Its precise properties and potential uses would depend on its specific chemical and structural characteristics, and further research and testing would be needed to determine its full range of potential applications.

Check Digit Verification of cas no

The CAS Registry Mumber 329794-09-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,9,7,9 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 329794-09:
(8*3)+(7*2)+(6*9)+(5*7)+(4*9)+(3*4)+(2*0)+(1*9)=184
184 % 10 = 4
So 329794-09-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H22N2OSi/c1-12(2,3)16(4,5)15-9-10-6-7-14-11(13)8-10/h6-8H,9H2,1-5H3,(H2,13,14)

329794-09-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (ADE000184)  4-(tert-Butyl-dimethyl-silanyloxymethyl)-pyridin-2-ylamine  AldrichCPR

  • 329794-09-4

  • ADE000184-1G

  • 1,930.50CNY

  • Detail

329794-09-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(tert-Butyl-dimethyl-silanyloxymethyl)-pyridin-2-ylamine

1.2 Other means of identification

Product number -
Other names 4-[[tert-butyl(dimethyl)silyl]oxymethyl]pyridin-2-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:329794-09-4 SDS

329794-09-4Synthetic route

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

2-amino-4-hydroxymethylpyridine
105250-17-7

2-amino-4-hydroxymethylpyridine

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 0 - 20℃; for 14h;86%
With 1H-imidazole In N,N-dimethyl-formamide at 0 - 20℃; for 3h;81%
Stage #1: 2-amino-4-hydroxymethylpyridine With 1H-imidazole In N,N-dimethyl-formamide at 0℃; for 0.0833333h;
Stage #2: tert-butyldimethylsilyl chloride In N,N-dimethyl-formamide at 0℃; for 12h;
62.49%
benzhydrylidene-[4-(tert-butyl-dimethyl-silanyloxymethyl)-pyridin-2-yl]-amine

benzhydrylidene-[4-(tert-butyl-dimethyl-silanyloxymethyl)-pyridin-2-yl]-amine

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

Conditions
ConditionsYield
With hydroxylamine In methanol at 20℃; for 18h;17.89 g
(2-chloropyridin-4-yl)methanol
100704-10-7

(2-chloropyridin-4-yl)methanol

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 97 percent / imidazole / tetrahydrofuran / 24 h / 20 °C
2: NaOtBu; BINAP racemic; Pd2(dba)3 / toluene / 5 h / 80 °C
3: 17.89 g / aq. hydroxylamine / methanol / 18 h / 20 °C
View Scheme
tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

MeHal

MeHal

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 97 percent / imidazole / tetrahydrofuran / 24 h / 20 °C
2: NaOtBu; BINAP racemic; Pd2(dba)3 / toluene / 5 h / 80 °C
3: 17.89 g / aq. hydroxylamine / methanol / 18 h / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2-chloropyridine
787596-40-1

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2-chloropyridine

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: NaOtBu; BINAP racemic; Pd2(dba)3 / toluene / 5 h / 80 °C
2: 17.89 g / aq. hydroxylamine / methanol / 18 h / 20 °C
View Scheme
cyclopropanecarboxylic acid
1759-53-1

cyclopropanecarboxylic acid

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

N-(4-(((tert-butyldimethylsilyl)oxy)methyl)pyridin-2-yl)cyclopropanecarboxamide

N-(4-(((tert-butyldimethylsilyl)oxy)methyl)pyridin-2-yl)cyclopropanecarboxamide

Conditions
ConditionsYield
Stage #1: cyclopropanecarboxylic acid With dmap In dichloromethane for 0.0833333h;
Stage #2: 4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 12h;
82.1%
Stage #1: cyclopropanecarboxylic acid With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 0.0833333h;
Stage #2: 4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine In dichloromethane at 20℃; for 12h;
82%
2-chloro-5-phenyl-thiazole
329794-40-3

2-chloro-5-phenyl-thiazole

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

[4-(tert-butyldimethylsilanyloxymethyl)pyridin-2-yl](5-phenylthiazol-2-yl)amine
329794-10-7

[4-(tert-butyldimethylsilanyloxymethyl)pyridin-2-yl](5-phenylthiazol-2-yl)amine

Conditions
ConditionsYield
Stage #1: 4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine With sodium hydride In tetrahydrofuran at 20℃;
Stage #2: 2-chloro-5-phenyl-thiazole In tetrahydrofuran for 2h; Heating;
79%
Benzoyl isothiocyanate
532-55-8

Benzoyl isothiocyanate

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

N-({[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-yl]amino}carbonothioyl)benzamide
872707-10-3

N-({[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-yl]amino}carbonothioyl)benzamide

Conditions
ConditionsYield
In toluene at 85℃; for 12h; Heating / reflux;79%
In toluene at 85℃; for 12h;79%
In toluene at 85℃; for 12h;79%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

tert-butyl (4-(((tert-butyldimethylsilyl)oxy)methyl)pyridin-2-yl)carbamate
864460-81-1

tert-butyl (4-(((tert-butyldimethylsilyl)oxy)methyl)pyridin-2-yl)carbamate

Conditions
ConditionsYield
With pyridine In ethyl acetate; tert-butyl alcohol at 20℃;62%
6-bromo-2-chloro-benzothiazole
80945-86-4

6-bromo-2-chloro-benzothiazole

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

6-bromo-N-(4-(((tert-butyldimethylsilyl)oxy)methyl)pyridin-2-yl)benzo[d]thiazol-2-amine
1377264-31-7

6-bromo-N-(4-(((tert-butyldimethylsilyl)oxy)methyl)pyridin-2-yl)benzo[d]thiazol-2-amine

Conditions
ConditionsYield
Stage #1: 4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine With sodium hydride In tetrahydrofuran at 0 - 20℃; for 0.5h;
Stage #2: 6-bromo-2-chloro-benzothiazole In tetrahydrofuran at 65℃; for 2h;
37%
4-cyano-1,2-phenylenediamine
17626-40-3

4-cyano-1,2-phenylenediamine

1,1'-Thiocarbonyldiimidazole
6160-65-2

1,1'-Thiocarbonyldiimidazole

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

2-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-yl]amino}-1H-benzimidazole-6-carbonitrile

2-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-yl]amino}-1H-benzimidazole-6-carbonitrile

Conditions
ConditionsYield
Stage #1: 1,1'-Thiocarbonyldiimidazole; 4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine With 1H-imidazole In dichloromethane at 0 - 20℃; for 72h;
Stage #2: 4-cyano-1,2-phenylenediamine In dichloromethane at 20℃; for 2h;
Stage #3: With diisopropyl-carbodiimide In dichloromethane at 20℃;
6%
2-chloro-1,3-thiazole-5-carbonitrile
51640-36-9

2-chloro-1,3-thiazole-5-carbonitrile

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

[4-(tert-butyldimethylsilanyloxymethyl)pyridin-2-ylamino]thiazole-5-carbonitrile
329794-13-0

[4-(tert-butyldimethylsilanyloxymethyl)pyridin-2-ylamino]thiazole-5-carbonitrile

Conditions
ConditionsYield
Stage #1: 4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine With sodium hydride In tetrahydrofuran for 0.25h;
Stage #2: 2-chloro-1,3-thiazole-5-carbonitrile In tetrahydrofuran for 2h; Heating;
23.4 g
With sodium hydride In tetrahydrofuran for 2h; Heating / reflux;
Stage #1: 4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine With sodium hydride In tetrahydrofuran for 0.25h;
Stage #2: 2-chloro-1,3-thiazole-5-carbonitrile for 2h; Heating / reflux;
With sodium hydride In tetrahydrofuran for 2h; Heating / reflux;
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

2-(4-chloromethyl-pyridin-2-ylamino)-thiazole-5-carbonitrile
329794-15-2

2-(4-chloromethyl-pyridin-2-ylamino)-thiazole-5-carbonitrile

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

2-(4-hydroxymethylpyridin-2-ylamino)thiazole-5-carbonitrile
329794-14-1

2-(4-hydroxymethylpyridin-2-ylamino)thiazole-5-carbonitrile

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

(4-chloromethylpyridin-2-yl)(5-phenylthiazol-2-yl)amine
329794-12-9

(4-chloromethylpyridin-2-yl)(5-phenylthiazol-2-yl)amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: NaH / tetrahydrofuran / 20 °C
1.2: 79 percent / tetrahydrofuran / 2 h / Heating
2.1: 98 percent / hydrogen fluoride-pyridine / tetrahydrofuran / 1 h / 0 °C
3.1: 90 percent / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 1.5 h
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

[2-(5-phenylthiazol-2-ylamino)pyridin-4-yl]methanol
329794-11-8

[2-(5-phenylthiazol-2-ylamino)pyridin-4-yl]methanol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaH / tetrahydrofuran / 20 °C
1.2: 79 percent / tetrahydrofuran / 2 h / Heating
2.1: 98 percent / hydrogen fluoride-pyridine / tetrahydrofuran / 1 h / 0 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

2-(4-morpholin-4-ylmethyl-pyridin-2-ylamino)-thiazole-5-carbonitrile

2-(4-morpholin-4-ylmethyl-pyridin-2-ylamino)-thiazole-5-carbonitrile

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: dimethylsulfoxide / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

(5-phenyl-thiazol-2-yl)-(4-pyrrolidin-1-ylmethyl-pyridin-2-yl)-amine

(5-phenyl-thiazol-2-yl)-(4-pyrrolidin-1-ylmethyl-pyridin-2-yl)-amine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 20 °C
1.2: 79 percent / tetrahydrofuran / 2 h / Heating
2.1: 98 percent / hydrogen fluoride-pyridine / tetrahydrofuran / 1 h / 0 °C
3.1: 90 percent / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 1.5 h
4.1: dimethylsulfoxide / 16 h / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

2-(4-piperazin-1-ylmethyl-pyridin-2-ylamino)-thiazole-5-carbonitrile

2-(4-piperazin-1-ylmethyl-pyridin-2-ylamino)-thiazole-5-carbonitrile

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: dimethylsulfoxide / 20 °C
5.1: 0.13 g / HCl (gas) / ethyl acetate / 2.5 h / 0 - 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

2-[4-(4-acetyl-piperazin-1-ylmethyl)-pyridin-2-ylamino]-thiazole-5-carbonitrile

2-[4-(4-acetyl-piperazin-1-ylmethyl)-pyridin-2-ylamino]-thiazole-5-carbonitrile

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: dimethylsulfoxide / 0.5 h / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

4-({2-[(5-cyano-1,3-thiazol-2-yl)amino]-4-pyridinyl}methyl)-1-piperazinecarboxamide

4-({2-[(5-cyano-1,3-thiazol-2-yl)amino]-4-pyridinyl}methyl)-1-piperazinecarboxamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: dimethylsulfoxide / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

2-[(4-{[4-(methylsulfonyl)piperidin-1-yl]methyl}pyridin-2-yl)amino]-1,3-thiazole-5-carbonitrile

2-[(4-{[4-(methylsulfonyl)piperidin-1-yl]methyl}pyridin-2-yl)amino]-1,3-thiazole-5-carbonitrile

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: 35 percent / diisopropylethylamine / dimethylsulfoxide / 17 h / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

4-({2-[(5-cyano-1,3-thiazol-2-yl)amino]-4-pyridinyl}methyl)-N,N-dimethyl-1-piperazinecarboxamide

4-({2-[(5-cyano-1,3-thiazol-2-yl)amino]-4-pyridinyl}methyl)-N,N-dimethyl-1-piperazinecarboxamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: 49 percent / dimethylsulfoxide / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

2-{4-[4-(2-hydroxy-ethanoyl)-piperazin-1-ylmethyl]-pyridin-2-ylamino}-thiazole-5-carbonitrile

2-{4-[4-(2-hydroxy-ethanoyl)-piperazin-1-ylmethyl]-pyridin-2-ylamino}-thiazole-5-carbonitrile

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: 33 percent / diisopropylethylamine / dimethylsulfoxide / 3 h / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

4-({2-[(5-cyanothiazol-2-yl)amino]pyridin-4-yl}methyl)piperazine-1-carboxylic acid methylamide
479611-82-0

4-({2-[(5-cyanothiazol-2-yl)amino]pyridin-4-yl}methyl)piperazine-1-carboxylic acid methylamide

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: 82 percent / triethylamine / dimethylsulfoxide / 16 h / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

1-{4-[2-(5-phenyl-thiazol-2-ylamino)-pyridin-4-ylmethyl]-piperazin-1-yl}-ethanone

1-{4-[2-(5-phenyl-thiazol-2-ylamino)-pyridin-4-ylmethyl]-piperazin-1-yl}-ethanone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 20 °C
1.2: 79 percent / tetrahydrofuran / 2 h / Heating
2.1: 98 percent / hydrogen fluoride-pyridine / tetrahydrofuran / 1 h / 0 °C
3.1: 90 percent / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 1.5 h
4.1: dimethylsulfoxide / 16 h / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

4-[2-(5-cyano-thiazol-2-ylamino)-pyridin-4-ylmethyl]-piperazine-1-carboxylic acid tert-butyl ester

4-[2-(5-cyano-thiazol-2-ylamino)-pyridin-4-ylmethyl]-piperazine-1-carboxylic acid tert-butyl ester

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 0.25 h
1.2: 23.4 g / tetrahydrofuran / 2 h / Heating
2.1: hydrogen fluoride-pyridine / tetrahydrofuran / 1 h
3.1: 15.5 g / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 4 h
4.1: dimethylsulfoxide / 20 °C
View Scheme
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

[4-(4-methanesulfonyl-piperazin-1-ylmethyl)-pyridin-2-yl]-(5-phenyl-thiazol-2-yl)-amine

[4-(4-methanesulfonyl-piperazin-1-ylmethyl)-pyridin-2-yl]-(5-phenyl-thiazol-2-yl)-amine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: NaH / tetrahydrofuran / 20 °C
1.2: 79 percent / tetrahydrofuran / 2 h / Heating
2.1: 98 percent / hydrogen fluoride-pyridine / tetrahydrofuran / 1 h / 0 °C
3.1: 90 percent / phosphorus oxychloride; N,N-dimethylformamide / CH2Cl2 / 1.5 h
4.1: Et3N / dimethylsulfoxide / 2.5 h / 20 - 45 °C
View Scheme
methyl 5,7-dichloro-1-(2-ethoxyethyl)-1H-pyrazolo-[4,3-d]pyrimidine-3-carboxylate
792970-11-7

methyl 5,7-dichloro-1-(2-ethoxyethyl)-1H-pyrazolo-[4,3-d]pyrimidine-3-carboxylate

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

methyl 7-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-yl]amino}-5-chloro-1-(2-ethoxyethyl)-1H-pyrazolo[4, 3-d]pyrimidine-3-carboxylate

methyl 7-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-yl]amino}-5-chloro-1-(2-ethoxyethyl)-1H-pyrazolo[4, 3-d]pyrimidine-3-carboxylate

Conditions
ConditionsYield
In dichloromethane at 20℃; for 18h;
4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine
329794-09-4

4-({[tert-butyl(dimethyl)silyl]oxy}methyl)pyridin-2-amine

N-(4-(hydroxymethyl)pyridin-2-yl)-6-(pyridin-4-yl)benzo[d]thiazol-2-amine
1377251-36-9

N-(4-(hydroxymethyl)pyridin-2-yl)-6-(pyridin-4-yl)benzo[d]thiazol-2-amine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: sodium hydride / tetrahydrofuran / 0.5 h / 0 - 20 °C
1.2: 2 h / 65 °C
2.1: potassium carbonate; lithium chloride / (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride / 1,4-dioxane; water / 1 h / 140 °C / microwave irradiation
3.1: hydrogenchloride / methanol / 2 h / 20 °C
View Scheme

329794-09-4Relevant articles and documents

Discovery of BAY-985, a Highly Selective TBK1/IKK? Inhibitor

Lefranc, Julien,Schulze, Volker Klaus,Hillig, Roman Christian,Briem, Hans,Prinz, Florian,Mengel, Anne,Heinrich, Tobias,Balint, Jozsef,Rengachari, Srinivasan,Irlbacher, Horst,St?ckigt, Detlef,B?mer, Ulf,Bader, Benjamin,Gradl, Stefan Nikolaus,Nising, Carl Friedrich,Von Nussbaum, Franz,Mumberg, Dominik,Panne, Daniel,Wengner, Antje Margret

supporting information, p. 601 - 612 (2020/02/04)

The serine/threonine kinase TBK1 (TANK-binding kinase 1) and its homologue IKK? are noncanonical members of the inhibitor of the nuclear factor κB (IκB) kinase family. These kinases play important roles in multiple cellular pathways and, in particular, in inflammation. Herein, we describe our investigations on a family of benzimidazoles and the identification of the potent and highly selective TBK1/IKK? inhibitor BAY-985. BAY-985 inhibits the cellular phosphorylation of interferon regulatory factor 3 and displays antiproliferative efficacy in the melanoma cell line SK-MEL-2 but showed only weak antitumor activity in the SK-MEL-2 human melanoma xenograft model.

HETEROARYLBENZIMIDAZOLE COMPOUNDS

-

Page/Page column 326, (2017/07/06)

The present invention covers heteroarylbenzimidazole compounds of general formula (I) in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative and/or inflammatory disorders, as a sole agent or in combination with other active ingredients.

1,3-THIAZOLE-5-CARBOXAMIDES USEFUL AS CANCER CHEMOTHERAPEUTIC AGENTS

-

Page/Page column 48, (2008/06/13)

This invention relates to novel 1, 3- thiazole-5 -carboxamide compounds of formula (I), pharmaceutical compositions containing such compounds, and the use of those compounds or compositions as cancer chemotherapeutic agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 329794-09-4